US Stock MarketDetailed Quotes

ITCI Intra-Cellular Therapies

Watchlist
  • 86.000
  • +0.760+0.89%
Close Dec 26 16:00 ET
  • 86.000
  • 0.0000.00%
Post 20:01 ET
9.12BMarket Cap-98.85P/E (TTM)

Intra-Cellular Therapies Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-4.97%-26.53M
101.47%542K
43.20%-34.12M
54.03%-124.2M
94.74%-2.06M
52.63%-25.27M
61.18%-36.8M
27.50%-60.07M
-4.10%-270.19M
46.45%-39.19M
Net income from continuing operations
-8.52%-26.32M
62.09%-16.22M
65.39%-15.25M
45.49%-139.67M
35.09%-28.58M
54.66%-24.26M
50.60%-42.78M
38.92%-44.05M
9.81%-256.26M
48.65%-44.03M
Depreciation and amortization
2.22%138K
4.88%129K
-1.49%132K
-19.51%528K
-4.90%136K
-20.59%135K
-28.49%123K
-21.64%134K
23.08%656K
-2.05%143K
Other non cash items
-25.00%18K
0.00%23K
4.55%23K
2.22%92K
4.55%23K
9.09%24K
4.55%23K
-8.33%22K
-49.72%90K
-35.29%22K
Change In working capital
-20.37%-16M
138.35%2.09M
-22.73%-30.52M
49.12%-29.58M
283.44%14.04M
-10.61%-13.29M
76.79%-5.46M
-66.35%-24.87M
-815.10%-58.14M
-303.00%-7.66M
-Change in receivables
101.58%106K
-0.96%-14.56M
-169.65%-17.14M
29.44%-38.83M
16.87%-11.35M
53.95%-6.71M
-1.94%-14.42M
49.86%-6.36M
-486.02%-55.03M
-323.81%-13.65M
-Change in inventory
-25.94%-1.37M
86.15%-1.88M
88.71%-499K
-64.96%-26.35M
-2,154.49%-7.28M
-176.56%-1.09M
20.87%-13.55M
-8,138.18%-4.42M
-1,690.58%-15.97M
-247.49%-323K
-Change in prepaid assets
-15.66%-18.95M
-176.93%-7.8M
-127.34%-24M
77.43%-4.46M
1,261.62%12.35M
-166.43%-16.39M
381.04%10.14M
-18.26%-10.56M
-76.20%-19.75M
-126.48%-1.06M
-Change in payables and accrued expense
-60.80%4.31M
112.11%26.44M
529.74%11.23M
28.77%41.26M
140.18%20.43M
51.03%10.99M
8.84%12.47M
-154.29%-2.61M
109.26%32.04M
202.42%8.5M
-Change in other current liabilities
9.78%-83K
-26.67%-114K
87.55%-115K
-310.28%-1.21M
91.00%-101K
-4,500.00%-92K
-4.65%-90K
-151.79%-924K
428.00%574K
-2,016.98%-1.12M
Cash from discontinued investing activities
Operating cash flow
-4.97%-26.53M
101.47%542K
43.20%-34.12M
54.03%-124.2M
94.74%-2.06M
52.63%-25.27M
61.18%-36.8M
27.50%-60.07M
-4.10%-270.19M
46.45%-39.19M
Investing cash flow
Cash flow from continuing investing activities
-937.35%-209.2M
-91.80%7.77M
198.28%16.18M
182.21%105.54M
-5.65%47.42M
-119.00%-20.17M
154.50%94.75M
94.89%-16.46M
-145.79%-128.37M
-2.42%50.26M
Net PPE purchase and sale
-159.70%-696K
----
----
65.42%-269K
-103.57%-1K
-129.06%-268K
----
----
-139.38%-778K
2,900.00%28K
Net investment purchase and sale
-947.83%-208.51M
-91.75%7.82M
198.28%16.18M
182.93%105.81M
-5.60%47.42M
-118.72%-19.9M
153.66%94.75M
94.88%-16.46M
-145.46%-127.6M
-2.48%50.24M
Cash from discontinued investing activities
Investing cash flow
-937.35%-209.2M
-91.80%7.77M
198.28%16.18M
182.21%105.54M
-5.65%47.42M
-119.00%-20.17M
154.50%94.75M
94.89%-16.46M
-145.79%-128.37M
-2.42%50.26M
Financing cash flow
Cash flow from continuing financing activities
160.91%6.73M
6,250.37%545.18M
174.42%9.99M
-96.09%17.81M
37.36%3M
-54.35%2.58M
55.98%8.59M
-99.18%3.64M
3,851.38%455.16M
-72.37%2.19M
Net common stock issuance
--0
----
----
--0
--0
--0
----
----
--433.72M
---7K
Proceeds from stock option exercised by employees
160.91%6.73M
-75.62%2.09M
174.42%9.99M
-16.93%17.81M
36.92%3M
-54.35%2.58M
55.98%8.59M
-55.00%3.64M
86.14%21.44M
-72.28%2.19M
Cash from discontinued financing activities
Financing cash flow
160.91%6.73M
6,250.37%545.18M
174.42%9.99M
-96.09%17.81M
37.36%3M
-54.35%2.58M
55.98%8.59M
-99.18%3.64M
3,851.38%455.16M
-72.37%2.19M
Net cash flow
Beginning cash position
382.65%695.06M
82.72%141.57M
-0.56%149.52M
60.36%150.37M
-26.22%101.15M
83.13%144.01M
-40.72%77.48M
60.36%150.37M
52.60%93.77M
27.51%137.11M
Current changes in cash
-434.33%-228.99M
731.92%553.49M
89.10%-7.95M
-101.50%-848K
264.83%48.37M
-173.29%-42.86M
227.80%66.53M
-297.37%-72.89M
75.13%56.6M
196.34%13.26M
End cash Position
360.75%466.06M
382.65%695.06M
82.72%141.57M
-0.56%149.52M
-0.56%149.52M
-26.22%101.15M
83.13%144.01M
-40.72%77.48M
60.36%150.37M
60.36%150.37M
Free cash flow
-6.59%-27.22M
101.33%489K
43.20%-34.12M
54.06%-124.47M
94.74%-2.06M
52.24%-25.54M
61.23%-36.8M
27.99%-60.07M
-4.27%-270.96M
46.48%-39.17M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -4.97%-26.53M101.47%542K43.20%-34.12M54.03%-124.2M94.74%-2.06M52.63%-25.27M61.18%-36.8M27.50%-60.07M-4.10%-270.19M46.45%-39.19M
Net income from continuing operations -8.52%-26.32M62.09%-16.22M65.39%-15.25M45.49%-139.67M35.09%-28.58M54.66%-24.26M50.60%-42.78M38.92%-44.05M9.81%-256.26M48.65%-44.03M
Depreciation and amortization 2.22%138K4.88%129K-1.49%132K-19.51%528K-4.90%136K-20.59%135K-28.49%123K-21.64%134K23.08%656K-2.05%143K
Other non cash items -25.00%18K0.00%23K4.55%23K2.22%92K4.55%23K9.09%24K4.55%23K-8.33%22K-49.72%90K-35.29%22K
Change In working capital -20.37%-16M138.35%2.09M-22.73%-30.52M49.12%-29.58M283.44%14.04M-10.61%-13.29M76.79%-5.46M-66.35%-24.87M-815.10%-58.14M-303.00%-7.66M
-Change in receivables 101.58%106K-0.96%-14.56M-169.65%-17.14M29.44%-38.83M16.87%-11.35M53.95%-6.71M-1.94%-14.42M49.86%-6.36M-486.02%-55.03M-323.81%-13.65M
-Change in inventory -25.94%-1.37M86.15%-1.88M88.71%-499K-64.96%-26.35M-2,154.49%-7.28M-176.56%-1.09M20.87%-13.55M-8,138.18%-4.42M-1,690.58%-15.97M-247.49%-323K
-Change in prepaid assets -15.66%-18.95M-176.93%-7.8M-127.34%-24M77.43%-4.46M1,261.62%12.35M-166.43%-16.39M381.04%10.14M-18.26%-10.56M-76.20%-19.75M-126.48%-1.06M
-Change in payables and accrued expense -60.80%4.31M112.11%26.44M529.74%11.23M28.77%41.26M140.18%20.43M51.03%10.99M8.84%12.47M-154.29%-2.61M109.26%32.04M202.42%8.5M
-Change in other current liabilities 9.78%-83K-26.67%-114K87.55%-115K-310.28%-1.21M91.00%-101K-4,500.00%-92K-4.65%-90K-151.79%-924K428.00%574K-2,016.98%-1.12M
Cash from discontinued investing activities
Operating cash flow -4.97%-26.53M101.47%542K43.20%-34.12M54.03%-124.2M94.74%-2.06M52.63%-25.27M61.18%-36.8M27.50%-60.07M-4.10%-270.19M46.45%-39.19M
Investing cash flow
Cash flow from continuing investing activities -937.35%-209.2M-91.80%7.77M198.28%16.18M182.21%105.54M-5.65%47.42M-119.00%-20.17M154.50%94.75M94.89%-16.46M-145.79%-128.37M-2.42%50.26M
Net PPE purchase and sale -159.70%-696K--------65.42%-269K-103.57%-1K-129.06%-268K---------139.38%-778K2,900.00%28K
Net investment purchase and sale -947.83%-208.51M-91.75%7.82M198.28%16.18M182.93%105.81M-5.60%47.42M-118.72%-19.9M153.66%94.75M94.88%-16.46M-145.46%-127.6M-2.48%50.24M
Cash from discontinued investing activities
Investing cash flow -937.35%-209.2M-91.80%7.77M198.28%16.18M182.21%105.54M-5.65%47.42M-119.00%-20.17M154.50%94.75M94.89%-16.46M-145.79%-128.37M-2.42%50.26M
Financing cash flow
Cash flow from continuing financing activities 160.91%6.73M6,250.37%545.18M174.42%9.99M-96.09%17.81M37.36%3M-54.35%2.58M55.98%8.59M-99.18%3.64M3,851.38%455.16M-72.37%2.19M
Net common stock issuance --0----------0--0--0----------433.72M---7K
Proceeds from stock option exercised by employees 160.91%6.73M-75.62%2.09M174.42%9.99M-16.93%17.81M36.92%3M-54.35%2.58M55.98%8.59M-55.00%3.64M86.14%21.44M-72.28%2.19M
Cash from discontinued financing activities
Financing cash flow 160.91%6.73M6,250.37%545.18M174.42%9.99M-96.09%17.81M37.36%3M-54.35%2.58M55.98%8.59M-99.18%3.64M3,851.38%455.16M-72.37%2.19M
Net cash flow
Beginning cash position 382.65%695.06M82.72%141.57M-0.56%149.52M60.36%150.37M-26.22%101.15M83.13%144.01M-40.72%77.48M60.36%150.37M52.60%93.77M27.51%137.11M
Current changes in cash -434.33%-228.99M731.92%553.49M89.10%-7.95M-101.50%-848K264.83%48.37M-173.29%-42.86M227.80%66.53M-297.37%-72.89M75.13%56.6M196.34%13.26M
End cash Position 360.75%466.06M382.65%695.06M82.72%141.57M-0.56%149.52M-0.56%149.52M-26.22%101.15M83.13%144.01M-40.72%77.48M60.36%150.37M60.36%150.37M
Free cash flow -6.59%-27.22M101.33%489K43.20%-34.12M54.06%-124.47M94.74%-2.06M52.24%-25.54M61.23%-36.8M27.99%-60.07M-4.27%-270.96M46.48%-39.17M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Broadcom
AVGO
+2.37%
Alibaba
BABA
+0.65%
Adobe
ADBE
+0.50%
Apple
AAPL
+0.32%
Cisco
CSCO
+0.22%

Unlock the Full List